Skip to content

Effects of Acute Ingestion of Dark Chocolate on Endothelial Function in Hypertensive Patients

Featuring Treated Hypertensive Patients Who Improve Endothelial Function After Dark Chocolate

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01314924
Enrollment
21
Registered
2011-03-15
Start date
2011-01-31
Completion date
2011-09-30
Last updated
2012-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Hypertension, Endothelial dysfunction, Vascular stiffness, Use of one or two antihypertensive drugs

Brief summary

We aimed to identify clinical and vascular parameters of treated hypertensive patients who present beneficial effects of dark chocolate for one-week period on vascular function.

Detailed description

Recent findings indicate an inverse relationship between cardiovascular disease and consumption of flavonoids. We aimed to identify clinical and vascular parameters of treated hypertensive patients who present beneficial effects of dark chocolate for one-week period on vascular function. Twenty-one hypertensive patients in drug therapy, both genders, aged 40-65 years, were included in a prospective study with measurement of blood pressure, brachial flow-mediated dilatation (FMD), peripheral arterial tonometry (EndoPAT) and central hemodynamic parameters by SphygmoCor. After seven days of eating dark chocolate (70% cocoa) 75g/day, the clinical and vascular evaluation were repeated. Patients were divided into two groups according to the response in FMD: responders (increase in FMD, n=12) and non-responders (no improvement in FMD, n=9).

Interventions

DIETARY_SUPPLEMENTDark chocolate

70% cocoa

Sponsors

Rio de Janeiro State Research Supporting Foundation (FAPERJ)
CollaboratorOTHER_GOV
Hospital Universitario Pedro Ernesto
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Previous diagnosis of hypertension * Use of one or two antihypertensive drugs * Systolic blood pressure between 130 and 160 mmHg * Diastolic blood pressure between 85 and 100 mmHg

Exclusion criteria

* Secondary hypertension * Diabetes mellitus * Body mass index \> 35kg/m2 * Chronic kidney disease * Known coronary artery disease * Previous stroke

Design outcomes

Primary

MeasureTime frameDescription
Endothelial functionOne weekEndothelial function evaluated by peripheral arterial tonometry and by flow-mediated dilation of brachial artery

Secondary

MeasureTime frameDescription
Blood pressureOne weekSystolic and diastolic blood pressure levels evaluated by an automatic device
Central hemodynamic parametersOne weekAortic systolic blood pressure and pulse pressure evaluated by SphygmoCor. Vascular stiffness parameters such as augmentation pressure and augmentation index will also be evaluated.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026